Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 33.50
-0.95 (-2.76%)
At close: Jan 28, 2026
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 13.34 billion as of February 3, 2026. Its market cap has increased by 113.41% in one year.
Market Cap
13.34B
Enterprise Value
13.18B
Revenue
674.49M
Ranking
n/a
PE Ratio
572.81
Stock Price
33.50
Market Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 13.34B, an increase of 61.52%. That is a compound annual growth rate of 13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 13.34B | 8.66% |
| Dec 31, 2025 | 12.28B | 93.40% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
| Mar 29, 2022 | 8.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guobang Pharma | 15.19B |
| ApicHope Pharmaceutical Group | 15.11B |
| Wedge Industrial | 14.16B |
| Shanghai Shyndec Pharmaceutical | 14.00B |
| Zhejiang Medicine | 13.60B |
| Zhejiang Jingxin Pharmaceutical | 13.53B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.36B |
| Porton Pharma Solutions | 13.20B |